Preferred Label : eplontersen sodium;
Origin ID : 000768285; M000768285;
Currated CISMeF NLP mapping
- Related record
https://www.ema.europa.eu/en/medicines/human/EPAR/wainzua
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
eplontersen
eplontersen
drug approval
europe
eplontersen
amyloidosis, hereditary, Transthyretin-Related
adult
injections, subcutaneous
oligonucleotides, antisense
oligonucleotides, antisense
risk management
eplontersen sodium
eplontersen sodium
product surveillance, postmarketing
pregnancy
breast feeding
Female of Childbearing Potential
drug evaluation, preclinical
---
